You have 9 free searches left this month | for more free features.

Pustular

Showing 1 - 25 of 716

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

CorEvitas Generalized Pustular Psoriasis Drug Safety and

Enrolling by invitation
  • Generalized Pustular Psoriasis
    • Waltham, Massachusetts
      CorEvitas, LLC
    Oct 23, 2023

    Generalized Pustular Psoriasis Trial (Spesolimab)

    Not yet recruiting
    • Generalized Pustular Psoriasis
    • (no location specified)
    Sep 4, 2023

    PMS of Spesolimab I.V. in GPP Patients With Acute Symptoms

    Not yet recruiting
    • Generalized Pustular Psoriasis
    • (no location specified)
    Jan 2, 2023

    Generalized Pustular Psoriasis Trial in Shandong (HB0034)

    Not yet recruiting
    • Generalized Pustular Psoriasis
    • Shandong, Shandong, China
      Shandong Provincial Dermatology Hospital
    Aug 22, 2022

    Generalized Pustular Psoriasis Trial in China (spesolimab)

    Recruiting
    • Generalized Pustular Psoriasis
    • Beijing, China
    • +10 more
    Jan 23, 2023

    Generalized Pustular Psoriasis Trial in Japan (spesolimab)

    Recruiting
    • Generalized Pustular Psoriasis
    • Aichi, Nagoya, Japan
    • +12 more
    Aug 10, 2022

    Generalized Pustular Psoriasis Trial in Worldwide (Imsidolimab)

    Completed
    • Generalized Pustular Psoriasis
    • Imsidolimab
    • Encino, California
    • +12 more
    Mar 2, 2022

    Palmoplantar Psoriasis, Genital Psoriasis Trial in Worldwide (Deucravacitinib, Placebo)

    Not yet recruiting
    • Palmoplantar Psoriasis
    • Genital Psoriasis
    • Birmingham, Alabama
    • +24 more
    Sep 12, 2023

    Generalized Pustular Psoriasis, Erythrodermic Psoriasis Trial in Japan (Ixekizumab)

    Completed
    • Generalized Pustular Psoriasis
    • Erythrodermic Psoriasis
    • Nagoya, Aichi, Japan
    • +6 more
    Jul 21, 2021

    Sneddon-Wilkinson, Acrodermatitis Continua of Hallopeau, Pustular Psoriasis Trial run by the NIAMS (Anakinra)

    Completed
    • Sneddon-Wilkinson
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 5, 2021

    Generalized Pustular Psoriasis Trial in Worldwide (Imsidolimab, Placebo)

    Recruiting
    • Generalized Pustular Psoriasis
    • Imsidolimab
    • Placebo
    • Largo, Florida
    • +66 more
    Sep 12, 2022

    Pustular Psoriasis (PP) Trial in Italy, Singapore, Switzerland (biological sampling, Phenotypic description, Photography)

    Recruiting
    • Pustular Psoriasis (PP)
    • biological sampling
    • +2 more
    • Rome, Italy
    • +3 more
    Jul 5, 2022

    Psoriasis Trial in Japan (risankizumab)

    Completed
    • Psoriasis
    • Nagoya-shi, Aichi, Japan
    • +8 more
    Nov 16, 2021

    Evaluate Safety and Efficacy of Cosentyx in Pediatric PsV, PsA,

    Recruiting
    • Psoriasis Vulgaris
    • +2 more
    • Cosentyx
    • Nagoya-city, Aichi, Japan
    • +23 more
    Aug 3, 2022

    Generalized Pustular Psoriasis Trial in Worldwide (Spesolimab, Placebo)

    Completed
    • Generalized Pustular Psoriasis
    • Birmingham, Alabama
    • +36 more
    Feb 11, 2022

    Generalized Pustular Psoriasis Trial in Worldwide (Spesolimab)

    Recruiting
    • Generalized Pustular Psoriasis
    • Auburn Hills, Michigan
    • +49 more
    Aug 22, 2022

    Palmoplantar Pustulosis and Generalized Pustular Psoriasis: A

    Unknown status
    • Palmoplantar Pustulosis
    • Generalized Pustular Psoriasis
    • prevalence/incidence
    • (no location specified)
    Sep 22, 2020

    Moderate-to-severe Psoriasis in Adults: Update of French

    Recruiting
    • Psoriasis
    • +10 more
    • Experts consensus
    • Paris, France
      Center of Evidence of Dermatology
    Nov 21, 2021

    Psoriasis Trial in Worldwide (Guselkumab 100 mg, Placebo)

    Completed
    • Psoriasis
    • Guselkumab 100 mg
    • Placebo
    • Bordeaux, France
    • +25 more
    Dec 30, 2021

    Generalized Pustular Psoriasis Trial in Worldwide (Imsidolimab high dose, Imsidolimab low dose, Placebo)

    Recruiting
    • Generalized Pustular Psoriasis
    • Imsidolimab high dose
    • +2 more
    • Largo, Florida
    • +59 more
    May 2, 2022

    Moderate to Severe Psoriasis, Generalized Pustular Psoriasis and Erythrodermic Psoriasis Trial in Japan (Placebo, Certolizumab

    Completed
    • Moderate to Severe Psoriasis
    • Generalized Pustular Psoriasis and Erythrodermic Psoriasis
    • Placebo
    • Certolizumab Pegol
    • Asahikawa, Japan
    • +32 more
    Dec 13, 2021

    Psoriasis Vulgaris, Psoriatic Arthritis, Pustular; Psoriasis, Palmaris Et Plantaris Trial in Tokyo (Brodalumab 210mg SC)

    Completed
    • Psoriasis Vulgaris
    • +3 more
    • Brodalumab 210mg SC
    • Tokyo, Japan
      The Jikei University Scoole of Medicine
    Dec 5, 2019

    Pustular Psoriasis Trial in Japan (Guselkumab)

    Completed
    • Pustular Psoriasis
    • Asahikawa, Japan
    • +19 more
    Oct 22, 2019

    Psoriasis Vulgaris, Psoriatic Arthritis, Pustular; Psoriasis, Palmaris Et Plantaris Trial in Chiyoda-ku (KHK4827 140mg SC,

    Completed
    • Psoriasis Vulgaris
    • +3 more
    • KHK4827 140mg SC
    • KHK4827 210mg SC
    • Chiyoda-ku, Tokyo, Japan
      For additional information regarding investigative sites for thi
    Nov 13, 2019

    Rosacea Trial (15% Trichloroacetic acid peel, 30% Salicylic acid peel)

    Not yet recruiting
    • Rosacea
    • 15% Trichloroacetic acid peel
    • 30% Salicylic acid peel
    • (no location specified)
    Jan 31, 2022